Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: jim-thompson who wrote (409585)	5/27/2003 2:24:21 PM
From: CYBERKEN	Respond to of 769670

I think they have to pass a law recognizing the existence of SARS before their slave/doctors can diagnose it...

To: jim-thompson who wrote (409585)	5/27/2003 2:27:01 PM
From: Bill	Read Replies (1) \| Respond to of 769670

They're waiting for a U.N. resolution before they can act...

To: jim-thompson who wrote (409585)	5/27/2003 2:35:18 PM
From: Kenneth E. Phillipps	Read Replies (1) \| Respond to of 769670

Canadian medicine is having great success with stem cell transplants for type 1 diabetes. The government pays for the procedure.

To: jim-thompson who wrote (409585)	5/27/2003 2:39:24 PM
From: Kenneth E. Phillipps	Read Replies (1) \| Respond to of 769670

Why is the US behind Germany in SARS research? German Group Develops SARS Antibody Test Tue May 27, 2003 10:29 AM ET BERLIN (Reuters Health) - A test that detects antibodies to the strain of coronavirus found in patients with severe acute respiratory syndrome (SARS) has been developed by researchers at the Robert Koch Institute in Berlin. The test uses a lab technique called immunflourescence to check for the presence of anti-coronavirus antibodies in the blood. "A test such as this one, which will soon be generally available, is an important step toward diagnosing the disease and gaining a better understanding of the progress of the disease," said Dr. Reinhard Kurth, president of the Robert Koch Institute. Kurth said the institute was working together with a company to make the test commercially available as soon as possible. Importantly, the test can distinguish between those patients who have been infected with the SARS coronavirus strains and those who have only come down with symptoms similar to SARS, the institute said. "This test will mean that doctors can quickly see whether a patient really does have SARS, or if a patient only has symptoms similar to the clinical symptoms of SARS," Kurth said. The new test will also help doctors gather vital information about how SARS spreads, according to the researchers. "With the help of this test, doctors will be able to find out how quickly SARS spreads between people and how. We will be able to find out whether there are people who are infected with the SARS virus, but who nevertheless do not come down with the clinical symptoms of SARS," Kurth said.

To: jim-thompson who wrote (409585)	5/30/2003 2:03:59 PM
From: Kenneth V. McNutt	Respond to of 769670

<<I have had some of the Canadian dumb clucks bash me for our high drug prices here in the U.S.>> Drug prices in Canada are lower than the US because we here in the States are subsidizing the Canadians. The drug business in Canada is about 1% of that of the US so the American drug companies bowed to the extortion of the Canadian government and charge us a little more each drug to help our Canadian friends whom are so mired in failed socialistic programs the average Canadian does not have enough money left to buy their own drugs unless we, the citizens of the US, helped them out. This is ok with me as when I go to Canada they give me a buck and a half per American dollar on every purchase. The majority of Canadians are great people, it is that few at the top that have caused their country to remain basically bankrupt. Also "idiots like "yields" don't help. Ken